Survey on practice of venom immunotherapy in France.
Fiche publication
Date publication
février 2016
Journal
Archives of medical science : AMS
Auteurs
Membres identifiés du Cancéropôle Est :
Pr BONNIAUD Philippe
Tous les auteurs :
Dzviga C, Matevi C, Bonniaud P, Lavaud F, Girodet B, Birnbaum J, Lambert C, ,
Lien Pubmed
Résumé
Venom immunotherapy (VIT) is the only efficient prevention for sting-induced anaphylaxis, but its application is not without risks and needs precautions and standardization. European guidelines were proposed in 2005, but recent practice surveys and more recent knowledge raise the need for an update. The aim of this study was to analyze VIT practices in France, based on previous surveys in Europe but also extended to outcome event management.
Mots clés
immunotherapy, practice survey, venom allergy
Référence
Arch Med Sci. 2016 Feb 1;12(1):150-5